|
gptkbp:instance_of
|
gptkb:business
|
|
gptkbp:acquired
|
gptkb:GE_Biopharma
|
|
gptkbp:collaborates_with
|
Research Institutions
|
|
gptkbp:develops
|
Innovative Technologies
|
|
gptkbp:employs
|
Thousands of employees
|
|
gptkbp:focuses_on
|
Life Sciences
|
|
gptkbp:headquartered_in
|
gptkb:Washington,_D._C.
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Danaher Corporation's Life Sciences segment
|
|
gptkbp:is_involved_in
|
gptkb:DNA
gptkb:Technical_Support
gptkb:Research_and_Development
gptkb:market_research
gptkb:Workshops
gptkb:market
gptkb:Clinical_Trials
gptkb:Partnerships
gptkb:Seminars
gptkb:customer_support
gptkb:logistics
gptkb:networking
gptkb:supply_chain_management
gptkb:Quality_Assurance
gptkb:intellectual_property
gptkb:Publications
Cell Biology
Conferences
Inventory Management
Manufacturing
Molecular Biology
Distribution
Product Development
Proteomics
Strategic Alliances
Regulatory Compliance
Webinars
Acquisitions
Patents
Diagnostics
Joint Ventures
Product Management
Training and Education
Collaborations
Sample Preparation
Sales and Marketing
Cell Culture
Bioprocessing
Assay Development
|
|
gptkbp:is_known_for
|
Quality Products
|
|
gptkbp:is_part_of
|
gptkb:Danaher_Operating_Companies
|
|
gptkbp:offers
|
Data Analytics Tools
Automation Solutions
|
|
gptkbp:operates_in
|
gptkb:biotechnology
Pharmaceuticals
Clinical Diagnostics
|
|
gptkbp:part_of
|
gptkb:Danaher_Corporation
|
|
gptkbp:provides
|
Consumables
Laboratory Instruments
Reagents
|
|
gptkbp:revenue
|
$7 billion (2022)
|
|
gptkbp:serves
|
Global Market
|
|
gptkbp:bfsParent
|
gptkb:Beckman_Coulter_Diagnostics
|
|
gptkbp:bfsLayer
|
5
|